Evgeniya Reshetnyak

Novartis (United States) — United States

Social Sciences · Social Sciences

17h-index3.9kcitations49works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health disparities and outcomes(11), COVID-19 and healthcare impacts(8), COVID-19 Clinical Research Studies(6), Healthcare Policy and Management(6), Iron Metabolism and Disorders(5)

Publications49 total

A phase III, multicenter, randomized, placebo controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide therapy, in adolescent and adult sickle cell disease patients with frequent vaso-occlusive crises: The sparkle study
Blood·2025
Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial
The Lancet Haematology·2025· 15 cited
Pharmacokinetics/Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease Aged 6 to <12 Years: 2-Year Data from the Phase 2 Solace-Kids Study
Blood·2024· 1 citedOpen Access
Social Determinants of Health and Cardiovascular Risk among Adults with Diabetes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Diabetes & Metabolism Journal·2024· 4 citedOpen Access
Development and validation of mortality prediction models based on the social determinants of health
Journal of Epidemiology & Community Health·2024· 1 citedOpen Access
The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study
Open Forum Infectious Diseases·2024· 3 citedOpen Access
Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease: final results from the phase II SOLACE-adults study
Therapeutic Advances in Hematology·2024· 6 citedOpen Access
Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease: Final Interim Analysis Results from the Phase 2 Solace-Adults Study
Blood·2023Open Access
Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study
Blood·2023· 26 cited
1130. Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure – Results from the placebo-controlled EMPATHY trial
Open Forum Infectious Diseases·2022· 2 citedOpen Access
Patterns Of Contraindications And Initiation Of Guideline-Directed Medical Therapy Among Older Adults With Heart Failure, With And Without Polypharmacy
Journal of Cardiac Failure·2022· 2 cited
Association between city-wide lockdown and COVID-19 hospitalization rates in multigenerational households in New York City
PLoS ONE·2022· 3 citedOpen Access
The Diagnostic Accuracy Of Procalcitonin for Urinary Tract Infection in Hospitalized Older Adults: a Prospective Study
Journal of General Internal Medicine·2022· 16 citedOpen Access
Abstract 9802: Social Determinants of Health and Cardiovascular Risk Among Adults with Diabetes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Circulation·2021
Association between City-wide Lockdown and COVID-19 Hospitalization Rates in Multigenerational Households in New York City
2021Open Access
Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study
Cancer·2021· 107 citedOpen Access
Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19
Circulation Heart Failure·2021· 37 citedOpen Access
Racial Disparities in Preventable Adverse Events Attributed to Poor Care Coordination Reported in a National Study of Older US Adults
Medical Care·2021· 8 citedOpen Access
Association between overcrowded households, multigenerational households, and COVID-19: a cohort study
Public Health·2021· 72 citedOpen Access
Association between overcrowded households, multigenerational households, and COVID-19: a cohort study
2021· 12 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Monika M. Safford(28), Laura C. Pinheiro(22), Mangala Rajan(12), Parag Goyal(10), Lisa M. Kern(10), Nathaniel Hupert(9), Joanna Bryan Ringel(8), Madeline R. Sterling(8), Emily B. Levitan(6), Orysya Soroka(6), Deborah Keefe(6), Paul Muntner(5), Arnab K. Ghosh(5), Sara Venkatraman(5), Anjile An(5), John K. Chae(5), Charles DiMaggio(5), Lisandro D. Colantonio(5), Lawrence P. Casalino(5), Michele L. Nassin(5)